FrancophonIA/ELRC3.0 huggingface dataset:
English: Tell your doctor: - if you have liver, kidney or heart problems, - if you experience any neurological symptoms such as headaches, changed mental state which may lead to confusion and coma, convulsions, blurred vision and high blood pressure as you may need to stop taking this medicine, - if you are taking other medicines mentioned in “Using other medicines” below, - if you have constipation, or if you are treated with medicines against pain (opioids), or if you have an abdominal cancer, or if you had abdominal surgery, - if you would like to father a child (see “Pregnancy, breast-feeding and fertility” below).
Danish: Tal med lægen: - hvis du har problemer med leveren, nyrerne eller hjertet, - hvis du oplever neurologiske symptomer såsom hovedpine, ændret mental tilstand (kan medføre forvirring og koma), kramper, sløret syn og højt blodtryk, da du måske er nødt til at stoppe med at få denne medicin, - hvis du tager anden medicin, som er nævnt under ”Brug af anden medicin sammen med Javlor”
English: Number of patients
Danish: Særlige patientgrupper
English: The recommended dose should be reduced in patients with haematological toxicity (see section 4.2).
Danish: Dosis bør nedsættes hos patienter med hæmatologisk toksicitet (se pkt.
English: Grade 3 was experienced by 0.6% patients.
Danish: 0,6 % af patienterne havde grad 3.
English: Mucositis or Constipation Grade 2 ≥ 5 days or Grade ≥ 3 any duration1
Danish: 2 ≥ 5 dage eller ≥ grad 3 af en hvilken som helst varighed1
English: Javlor may cause adverse reactions such as fatigue (very common) and dizziness (common) which may lead to a minor or moderate influence on the ability to drive and use machines..Patients should be advised not to drive or use machines if they experience any adverse reaction with a potential impact on the ability to perform these activities (see section 4.8).
Danish: Javlor kan forårsage bivirkninger såsom træthed (meget almindelig) og svimmelhed (almindelig), som kan have mindre eller moderat indvirkning på evnen til at føre motorkøretøj og betjene maskiner.
English: Fatal if given by other routes.
Danish: KUN til intravenøs anvendelse, efter fortynding Kan medføre døden, hvis givet ad andre veje.
English: Hepatic impairment The recommended dose should be reduced in patients with hepatic impairment (see section 4.2).
Danish: Nedsat leverfunktion Den anbefalede dosis bør reduceres til patienter med nedsat leverfunktion (se pkt.
English: How to use Javlor
Danish: Sådan skal du bruge Javlor Dosering
English: • After the infusion is completed, the remaining 250 mL from the sodium chloride 9 mg/mL (0.9%) solution for infusion or of glucose 50 mg/mL (5%) solution for infusion bag should be run at a flowing rate of 300 mL/h.
Danish: • Når infusionen er færdig, bør det resterende 250 ml af natriumchlorid 9 mg/ml (0,9 %) infusionsvæske, opløsning eller glucose 50 mg/ml (5 %) infusionsvæske, opløsning fra infusionsposen løbe i en flydende hastighed på 300 ml/time.
English: Method of administration Javlor is for intravenous use ONLY.
Danish: Indgivelsesmåde KUN til intravenøs anvendelse.
English: Vinflunine initial dose of 250 mg/m²
Danish: Initial vinflunindosis på 250 mg/m²
English: EXP: Read the leaflet for the shelf life of diluted medicine.
Danish: Udløbsdato Se indlægssedlen for opbevaringstid for det fortyndede lægemiddel.
English: When adjusted on prognostic factors, the analyses of OS in the subgroups of patients without or with prior cisplatin showed a HR (95% CI) = [0.53 (0.32 - 0.88); p=0.0143] and a HR (95% CI) = [0.70 (0.530.94); p=0.0174], respectively.
Danish: Ved justering af de prognostiske faktorer viste analyserne af OS i delgrupperne af patienter uden tidligere brug af cisplatin et HR på (95% CI) = [0,53 (0,32-0,88); p=0,0143] og med tidligere brug af cisplatin et HR på (95% CI) = [0,70 (0,53-0,94); p=0,0174].
English: Dose adjustments are recommended in patients with moderate and severe renal impairment (see section 4.2).
Danish: Dosisjustering anbefales til patienter med moderat og svært nedsat nyrefunktion (se pkt.
English: Very common Asthenia/Fatigue Injection site reaction Pyrexia
Danish: Reaktion på injektionsstedet Pyreksi
English: In the eligible population, the subgroup analyses according to the prior cisplatin use versus BSC on overall survival (OS) showed a HR (95% CI) = [0.64 (0.40 - 1.03); p=0.0821] in the absence of prior cisplatin, and a HR (95% CI) = [0.80 (0.60 - 1.06); p=0.1263] in the presence of prior cisplatin.
Danish: I den population, der var egnet til behandling, viste subgruppeanalyserne i overensstemmelse med den tidligere brug af cisplatin i forhold til BSC for den samlede overlevelse (OS) et HR (95% CI) = [0,64 (0,40 - 1,03); p=0,0821] ved fravær af tidligere brug af cisplatin, og et HR på (95% CI) = [0,80 (0,60 - 1,06); p=0,1263] ved forekomst af tidligere brug af cisplatin.
English: In the subgroup analyses of prior cisplatin use versus BSC for progression free survival (PFS), the results were: HR (95% CI) = [0.55 (0.34 - 0.89); p=0.0129] in the absence of prior cisplatin, and a HR (95% CI) = [0.64 (0.48 - 0.85); p=0.0040] in the presence of prior cisplatin.
Danish: I subgruppeanalyserne af tidligere brug af cisplatin i forhold til BSC for progressionsfri overlevelse (PFS) var resultaterne: HR (95% CI) = [0,55 (0,34-0,89); p=0,0129] ved fravær af tidligere brug af cisplatin, og HR (95% CI) = [0,64 (0,48-0,85); p=0,0040] ved forekomst af tidligere brug af cisplatin.
English: To prevent constipation you may be given laxatives.
Danish: Du vil eventuelt få afføringsmidler for at forebygge forstoppelse.
English: - chills, excessive sweating - allergy, dehydration, headache, skin rash, itching - digestive problems, pain in the mouth, on the tongue and toothache, taste alteration - muscular weakness, pain in jaw, pain in extremity, back pain, pain in joints, muscular pain, bone pain, ear pain - dizziness, insomnia, transiant loss of consciousness - difficulties with body movements - fast heartbeat, raised blood pressure, reduced blood pressure - breathing difficulties, cough, chest pain - swelling of your arms, hands, feet, ankles, legs or other parts of your body - inflammation of the veins (phlebitis).
Danish: muskelsmerter, smerter i knoglerne, øresmerter - svimmelhed, søvnløshed, forbigående bevidsthedstab - vanskeligheder med bevægeapparatet - hurtige hjerteslag (puls), forhøjet blodtryk, nedsat blodtryk - problemer med vejrtrækningen, hoste, smerter i brystet - hævede arme, hænder, fødder, ankler, ben og andre dele af kroppen - årebetændelse (flebitis).
English: Skin and subcutaneous tissue disorders
Danish: Hud og subkutane væv Meget almindelige
English: However, dose adjustments are recommended in patients with liver impairment (see section 4.2).
Danish: Dosisjusteringer anbefales dog til patienter med nedsat leverfunktion (se pkt.
English: Decreased appetite Common Dehydration
Danish: Almindelige Dehydrering
English: Infections and infestations Common Neutropenic infection Infections (viral, bacterial, fungal) Uncommon Neutropenic sepsis
Danish: Infektioner (virus-, bakterie-, svampe
English: What Javlor is and what it is used for What you need to know before you use Javlor How to use Javlor
Danish: Det skal du vide, før du begynder at bruge Javlor Sådan skal du bruge Javlor Bivirkninger
English: In order to flush the vein, administration of Javlor solution for infusion should always be followed by at least an equal volume of sodium chloride 9 mg/mL (0.9%) solution for infusion or of glucose 50 mg/mL (5%) solution for infusion.
Danish: For at gennemskylle venen skal indgiften af Javlor-opløsningen til infusion altid efterfølges med mindst en lige så stor mængde natriumchloridopløsning på 9 mg/ml (0,9 %) til infusion eller glucoseopløsning 50 mg/ml (5 %) til infusion.
English: When adjusted on prognostic factors, the analyses of PFS in the subgroups of patients without or with prior cisplatin showed a HR (95% CI) = [0.51(0.31 - 0.86); p=0.0111] and a HR (95% CI) = [0.63(0.48 - 0.84); p=0.0016], respectively.
Danish: Ved justering af de prognostiske faktorer viste analyserne af PFS i delgrupperne af patienter uden tidligere brug af cisplatin et HR på (95% CI) = [0,51(0,31-0,86); p=0,0111] og med tidligere brug af cisplatin et HR på (95% CI) = [0,63(0,48-0,84); p=0,0016].
English: Dose adjustment Vinflunine initial dose of 280 mg/m²
Danish: Dosisjustering Initial vinflunindosis på 280 mg/m²
English: Each mL of concentrate contains 25 mg of vinflunine (as ditartrate).
Danish: Hver ml af koncentratet indeholder 25 mg af vinflunin (som ditartrat).
English: • The intravenous infusion should be started with half of the 500 mL bag of sodium chloride 9 mg/mL (0.9%) solution for infusion or of glucose 50 mg/mL (5%) solution for infusion, i.e. 250 mL, at a free flowing rate to flush the vein.
Danish: • Den intravenøse infusion bør påbegyndes med halvdelen af 500 ml-posen med natriumchlorid 9 mg/ml (0,9 %) infusionsvæske, opløsning eller glucose 50 mg/ml (5 %) infusionsvæske, opløsning, dvs. 250 ml, med en fritløbende hastighed for at vurdere passagen i venen.
English: • A venous access should be established for a 500 mL bag of sodium chloride 9 mg/mL (0.9%) solution for injection or glucose 50 mg/mL (5%) solution for infusion, on a large vein preferably in the upper part of the forearm or using a central venous line.
Danish: • Der bør etableres en veneadgang til en 500 ml pose med natriumchlorid 9 mg/ml (0,9 %) infusionsvæske, opløsning eller glucose 50 mg/ml (5 %) infusionsvæske, opløsning, i en større vene, helst i den øvre del af underarmen, eller ved brug af et centralt venekateter.
English: Pierre Fabre Médicament 45 place Abel Gance F-92100 Boulogne France
Danish: Pierre Fabre Médicament 45 place Abel Gance F-92100 Boulogne Frankrig
English: Pierre Fabre Médicament 45, place Abel Gance F-92100 Boulogne France
Danish: Pierre Fabre Médicament 45, place Abel Gance F-92100 Boulogne Frankrig
English: One 4 mL vial contains 100 mg of vinflunine (as ditartrate).
Danish: Et 4 ml hætteglas indeholder 100 mg vinflunin (som ditartrat).
English: Uncommon Renal failure
Danish: Almindelige Febril neutropeni
English: Tinnitus
Danish: Neuralgi
English: Thrombocytopenia (platelets < 100,000/mm3)
Danish: Neutropeni (ANC < 1.000/mm3) eller trombocytopeni (blodplader < 100.000/mm3)
English: Pharyngolaryngeal pain
Danish: ARDS (respiratory distress syndrome) Faryngolaryngeale smerter
English: Buccal disorders Dyspepsia
Danish: Almindelige Dyspnø Hoste
English: Common Rash Urticaria
Danish: Almindelige Udslæt Urticaria
English: In order to flush the vein, administration of diluted Javlor should always be followed by at least an equal volume of sodium chloride 9 mg/mL (0.9%) solution for infusion or of glucose 50 mg/mL (5%) solution for infusion.
Danish: For at gennemskylle venen skal indgiften af Javlor altid efterfølges med mindst en lige så stor mængde natriumchlorid 9 mg/ml (0,9 %) infusionsvæske, opløsning eller glucose 50 mg/ml (5 %) til infusionsvæske, opløsning.
English: Treatment discontinuation
Danish: behandlingen behandlingen
English: IV use ONLY, after dilution
Danish: anvendelse, efter fortynding
English: Febrile Neutropenia (ANC < 1,000/mm3 and fever ≥ 38,5 °C) Mucositis or Constipation Grade 2 ≥ 5 days or Grade ≥ 3 any duration1
Danish: Febril neutropeni (ANC< 1.000/mm3 og feber ≥ 38,5 °C)1
English: Vinflunine initial dose of 280 mg/m²
Danish: Indledende dosis af vinflunin på 280 mg/m²
English: Interactions
Danish: Bivirkninger
English: The recommended dose should be reduced in patients with moderate or severe renal impairment (see section 4.2).
Danish: Nedsat nyrefunktion Den anbefalede dosis bør reduceres til patienter med moderat eller svært nedsat nyrefunktion (se pkt.
English: You must not breastfeed during treatment with Javlor If you would like to father a child, seek advice from your doctor.
Danish: Hvis du ønsker at gøre en kvinde gravid, skal du søge vejledning hos din læge.
English: One mL of concentrate contains 25 mg of vinflunine (as ditartrate).
Danish: En ml koncentrat indeholder 25 mg vinflunin (som ditartrat).
English: Javlor 25 mg/mL concentrate for solution for infusion vinflunine
Danish: Javlor 25 mg/ml koncentrat til infusionsvæske, opløsning vinflunin
English: Uncommon Extravasation
Danish: Almindelige Overfølsomhed
English: Javlor 25 mg/mL concentrate for solution for infusion
Danish: Javlor 25 mg/ml koncentrat til infusionsvæske, opløsning
English: Very common Hyponatraemia
Danish: Vaskulære sygdomme Almindelige Hypertension Venetrombose
English: One 10 mL vial contains 250 mg of vinflunine (as ditartrate).
Danish: Et 10 ml hætteglas indeholder 250 mg vinflunin (som ditartrat).
English: 280 mg/m² 250 mg/m²
Danish: 280 mg/m²
English: Clear type I glass vials closed by a grey butyl or black chlorobutyl rubber stopper covered with a crimped-on aluminium ring and a cap. Each vial contains either 2 mL (50 mg vinflunine), 4 mL (100 mg vinflunine) or 10 mL (250 mg vinflunine) of concentrate for solution for infusion.
Danish: Hvert hætteglas indeholder enten 2 ml (50 mg vinflunin), 4 ml (100 mg vinflunin) eller 10 ml (250 mg vinflunin) koncentrat til infusionsvæske, opløsning.
English: Renal impairment
Danish: Asteni/træthed
English: One 2 mL vial contains 50 mg of vinflunine (as ditartrate).
Danish: Et 2 ml hætteglas indeholder 50 mg vinflunin (som ditartrat).
English: Nausea
Danish: Nyresvigt
English: Gingival disorders
Danish: Dysgeusi
English: Uncommon Acute respiratory distress syndrome
Danish: Obstipation Abdominalsmerter Opkastning Kvalme
English: Bone pain
Danish: Se pkt.
English: Psychiatric disorders
Danish: Bukkale sygdomme
English: Common Tachycardia Uncommon Myocardial ischaemia
Danish: Almindelige Takykardi Ikke almindelige
English: Common Chest pain Chills
Danish: Almindelige Brystsmerter Kuldegysninger Smerte
English: Justification for not including Braille accepted.
Danish: Fritaget for krav om brailleskrift
English: This leaflet was last revised in MM/YYYY Other sources of information
Danish: Denne indlægsseddel blev senest ændret {måned ÅÅÅÅ}.
English: Recommended co-medication
Danish: Anbefalet samtidig indgift af andre lægemidler
English: Doctors and patients must be aware of this possibility.
Danish: Både læger og patienter skal være opmærksomme på denne mulighed.
English: The patient or their partner may carry out the injections.
Danish: Patienten eller dennes partner kan give injektionerne.
English: This medicine is the same as Puregon, which is already authorised in the European Union (EU).
Danish: Lægemidlet er identisk med Puregon, som allerede er godkendt i Den Europæiske Union (EU).
English: The European Commission granted a marketing authorisation valid throughout the European Union for Fertavid on 19 March 2009.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Fertavid den 19. marts 2009.
English: The full EPAR for Fertavid can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Fertavid findes på agenturets websted: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This is a summary of the European public assessment report (EPAR) for Fertavid.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Fertavid.
English: Fertavid is given as an injection under the skin or into a muscle.
Danish: Fertavid gives som en injektion under huden eller i en muskel.
English: The dose and frequency of administration of Fertavid depend on its use (see above) and the patient's response to treatment.
Danish: Dosis og indgivelseshyppighed af Fertavid afhænger af brugen (se ovenfor) og patientens reaktion på behandlingen.
English: In the body, FSH regulates reproductive function: in women, it stimulates the production of eggs, and in men, it stimulates the production of sperm by the testicles.
Danish: I kroppen regulerer FSH forplantningsevnen: Hos kvinder stimulerer det produktionen af æg, og hos mænd stimulerer det produktionen af sæd i testiklerne.
English: Fertavid was studied in 172 anovulatory women, measuring how many cycles of treatment were needed for these women to ovulate.
Danish: Fertavid blev undersøgt hos 172 anovulatoriske kvinder, hvor man målte, hvor mange behandlingscyklusser der skulle til, for at disse kvinder fik ægløsning.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Fertavid.
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om anvendelsesbetingelserne for Fertavid.
English: Treatment with Fertavid should be carried out by a doctor who has experience in the treatment of fertility problems.
Danish: Behandling med Fertavid skal foretages af en læge med erfaring i behandling af fertilitetsproblemer.
English: Fertavid is administered to stimulate the ovaries to produce more than one egg at a time.
Danish: Fertavid indgives for at stimulere æggestokkene til at producere mere end ét æg ad gangen.
English: EPAR summary for the public follitropin beta
Danish: EPAR - sammendrag for offentligheden follitropin beta
English: For more information about treatment with Fertavid, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Fertavid, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: Other information about Fertavid
Danish: Andre oplysninger om Fertavid:
English: Ovarian hyperstimulation syndrome occurs when the ovaries over-respond to treatment.
Danish: Ovarielt hyperstimulationssyndrom opstår, når æggestokkene overreagerer på behandlingen.
English: • women who are anovulatory (do not produce eggs) and do not respond to treatment with clomiphene citrate (another medicine that stimulates ovulation);
Danish: • Kvinder, der er anovulatoriske (ikke producerer æg) og ikke reagerer på behandling med clomifencitrat (et andet lægemiddel, der stimulerer ægløsning).
English: Fertavid's use in women undergoing fertility treatment has been studied in 981 patients.
Danish: Anvendelsen af Fertavid til kvinder i fertilitetsbehandling er blevet undersøgt hos 981 patienter.
English: The most common side effects with Fertavid are a reaction and pain at the injection site.
Danish: De hyppigste bivirkninger ved Fertavid er en reaktion eller smerter ved injektionsstedet.
English: Fertavid is used to treat infertility in women in the following situations:
Danish: Fertavid anvendes til behandling af kvindelig infertilitet i følgende situationer:
English: The company that makes Puregon has agreed that its scientific data can be used for Fertavid.
Danish: Virksomheden, som fremstiller Puregon, har givet tilladelse til, at dets videnskabelige oplysninger må anvendes for Fertavid.
English: Fertavid should only be administered by people who have been trained by the doctor and have access to expert advice.
Danish: Fertavid bør kun gives af personer, som er blevet instrueret af en læge og har adgang til ekspertrådgivning.
English: The CHMP decided that Fertavid's benefits are greater than its risks and recommended that Fertavid be given marketing authorisation.
Danish: CHMP besluttede, at fordelene ved Fertavid er større end risiciene, og anbefalede udstedelse af markedsføringstilladelse for Fertavid.
English: In 4% of the women treated with Fertavid in clinical studies, signs and symptoms related to ovarian hyperstimulation syndrome (e.g. feeling sick, weight gain and diarrhoea) have been reported.
Danish: Hos 4 % af de kvinder, der fik behandling med Fertavid i kliniske undersøgelser, er der indberettet tegn og symptomer på ovarielt hyperstimulationssyndrom (f.eks. kvalme, vægtøgning og diarré).
English: Fertavid can also be used to stimulate sperm production in men who have hypogonadotrophic hypogonadism (a rare hormone deficiency disease).
Danish: Fertavid kan også anvendes til at stimulere sædproduktionen hos mænd med hypogonadotrop hypogonadisme (en sjælden hormondefektsygdom).
English: Fertavid should not be used in people who may be hypersensitive (allergic) to follitropin beta or any of the other ingredients.
Danish: Fertavid må ikke anvendes af personer, der kan være overfølsomme (allergiske) over for follitropin beta eller et eller flere af de øvrige indholdsstoffer.
English: In men, Fertavid was studied to see its effect on sperm production in 49 patients.
Danish: Hos mænd blev Fertavid undersøgt for at måle effekten på sædproduktionen hos 49 patienter.
English: Fertavid can only be obtained with a prescription.
Danish: Fertavid udleveres kun efter recept.
English: It must not be used in men with testicular failure.
Danish: Det må ikke anvendes til mænd med testikelinsufficiens.
English: The number of eggs recovered and the ongoing pregnancy rate were the main measures of effectiveness.
Danish: Det primære effektmål var det antal æg, der kunne udtages, og frekvensen af igangværende graviditeter.
English: What is the risk associated with Fertavid?
Danish: Hvilken risiko er der forbundet med Fertavid?
English: In all of the studies, Fertavid was compared with the natural FSH hormone that was extracted from urine.
Danish: I alle undersøgelserne blev Fertavid sammenlignet med det naturlige FSH-hormon, der blev udvundet af urin.
English: • women who are undergoing fertility treatment (assisted reproductive techniques, such as in vitro fertilisation).
Danish: • Kvinder, der modtager fertilitetsbehandling (kunstig befrugtning såsom in vitro-befrugtning).
English: Fertavid is a solution for injection that contains the active substance follitropin beta.
Danish: Fertavid er en injektionsvæske, der indeholder det aktive stof follitropin beta.
English: Fertavid must not be used in patients with tumours of the ovary, breast, womb, testicle, pituitary gland or hypothalamus.
Danish: Fertavid må ikke anvendes til patienter med svulster i æggestokkene, brystet, livmoderen, testiklerne, hypofysen eller hypothalamus.
English: Why has Fertavid been approved?
Danish: Hvorfor blev Fertavid godkendt?
English: The active substance in Fertavid, follitropin beta, is a copy of the natural hormone follicle stimulating hormone (FSH).
Danish: Det aktive stof i Fertavid, follitropin beta, er en kopi af det naturlige hormon FSH (follikelstimulerende hormon).
English: Fertavid was as effective as the comparator in all of the studies.
Danish: I alle undersøgelserne var Fertavid lige så effektivt som sammenligningsstoffet.
English: Fertavid was as effective as urinary FSH as a fertility treatment, in producing ovulation and in producing sperm.
Danish: Som fertilitetsbehandling var Fertavid lige så effektivt som FSH fra urin og lige så effektivt til at fremkalde ægløsning og stimulere sædproduktion.
English: Previously, the FSH used as a medicine was extracted from urine.
Danish: Tidligere blev FSH udvundet af urin til brug som lægemiddel.
English: What is Fertavid?
Danish: Hvad er Fertavid?
English: For a full list of all side effects reported with Fertavid, see the package leaflet.
Danish: Den fuldstændige liste over de indberettede bivirkninger ved Fertavid fremgår af indlægssedlen.
English: For a full description of the doses, see the package leaflet.
Danish: En fuldstændig beskrivelse af doseringen fremgår af indlægssedlen.
English: What is Fertavid used for?
Danish: Hvad anvendes Fertavid til?
English: In women, it must not be used when there is ovarian failure, ovarian enlargement or the presence of cysts that are not due to polycystic ovarian disease, or vaginal bleeding.
Danish: forstørrede æggestokke eller cyster på æggestokkene, der ikke skyldes polycystisk ovariesyndrom eller vaginal blødning.
English: How has Fertavid been studied?
Danish: Hvordan blev Fertavid undersøgt?